This information was published on 2025-03-27T04:15:37 for IP Right Filed Published.
| Field | Value |
| (210) | 2534250 (IR 1418734) |
| (220) |
28 Feb 2025
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceuticals; medicines for allergen-specific immunotherapy. |
| (540) | ROXSIT |
| (550) | Word |
| (730) |
ROXALL Medizin GmbH
|
Find out more about publications on the About page.